🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

20 recruiting trials

for Short-course Radiotherapy Plus Chemotherapy

Short-course Radiotherapy Followed by Sequential Chemotherapy With or Without PD-1 Monoclonal Antibody and Bevacizumab as Total Neoadjuvant Therapy in pMMR/MSS Locally Advanced Rectal Cancer （SPARK） NCT07005570Phase 21 site📍 Guangzhou Dechang Diao · Tests: Short-course radiotherapy followed by sequential chemotherapy combined with PD-1 monoclonal antibody and bevacizumab, S… Short-Course Radiotherapy Followed by Immunotherapy Combined With Chemotherapy for Microsatellite Stable Locally Advanced Rectal Cancer: A Prospective, Randomized, Controlled Phase II Clinical Trial NCT07594925Phase 21 site📍 Tianjin Tianjin Medical University Cancer Institute and Hospital · Tests: Sintilimab, Chemotherapy Drugs, radiotherapy A Study of Short-Course Radiation Therapy With Chemotherapy in People With Endometrial Cancer NCT05691010EARLY Phase 17 sites📍 Basking Ridge📍 Middletown📍 Montvale Memorial Sloan Kettering Cancer Center · Tests: Intensity-modulated radiation therapy, Carboplatin, Paclitaxel Adebrelimab Injection (PD-L1) Combined With Short Course Radiotherapy and Chemotherapy for Neoadjuvant Therapy of Locally Advanced Rectal Cancer NCT06765616Phase 21 site📍 Jinan Feng Tian · Tests: Adebrelimab Injection combined with radiotherapy and chemotherapy Short Course Radiation Therapy and Combination Chemotherapy for the Treatment of Stage II-III Rectal Cancer NCT04703101Phase 11 site📍 Los Angeles Jonsson Comprehensive Cancer Center · Tests: Capecitabine, Fluorouracil, Intensity-Modulated Radiation Therapy, Leucovorin, Oxaliplatin A Single-center, Phase II Study on Efficacy & Safety of SCRT+CAPOX+Serplulimab+Bevacizumab for MSS Rectal Cancer NCT07347951Phase 21 site📍 Wenzhou First Affiliated Hospital of Wenzhou Medical University · Tests: Short-course radiotherapy, CAPOX chemotherapy, Targeted therapy with bevacizumab, Serplulimab immunotherapy SCRT Combined With Chemotherapy and Iparomlimab and Tuvonralimab in MSS or pMMR Patients With Locally Advanced Rectal Cancer NCT06864013Phase 21 site📍 Hangzhou First Affiliated Hospital of Zhejiang University · Tests: Experimental, Control Node-Sparing Short-Course Radiotherapy Sequential Chemotherapy and PD-1 Inhibitor for Mid/Low pMMR/MSS Rectal Cancer (MODIFI-RC-II) NCT06958432Phase 2, Phase 31 site📍 Guangzhou Sixth Affiliated Hospital, Sun Yat-sen University · Tests: Node-Sparing Radiotherapy plus Chemotherapy and PD-1 inhibitor, Conventional Radiotherapy plus Chemotherapy SCRT-CAPEOX-Serplulimab for MSS/pMMR Rectal Cancer With Oligometastases NCT06850103Phase 21 site📍 Hangzhou First Affiliated Hospital of Zhejiang University · Tests: short-course radiotherapy, CAPEOX/XELOX, Serplulimab, surgery A Phase I-II Study to Test the Safety and Efficacy of PD1 (AB122) and Adenosine Receptor (AB928) Antagonists With Chemotherapy After Short-Course Radiation for Rectal Cancer. NCT05024097Phase 23 sites📍 New York📍 New York📍 New York Weill Medical College of Cornell University · Tests: Etrumadenant (AB928), Radiation therapy, FOLFOX regimen, Zimberelimab (AB122) SCRT + Chemo Targeted Immuno-neoadjuvant Therapy for High-risk pMMR/MSS RC NCT07549399Phase 31 site📍 Guangzhou Sixth Affiliated Hospital, Sun Yat-sen University · Tests: Short-Course Radiotherapy, PD-1 monoclonal antibody, mFOLFOX6 regimen, Cetuximab, Bevacizumab Neoadjuvant Short-Course Radiotherapy With or Without Chemotherapy and AK112 in Locally Advanced Rectal Cancer NCT06718543Phase 21 site📍 Chongqing fan li · Tests: AK112 with SCRT and CapeOX, AK112 with SCRT Nodal-Region Sparing Short-Course RT With Chemo-PD-1/Bevacizumab vs. Short-Course RT With Chemotherapy as TNT in pMMR/MSS Locally Advanced Rectal Cancer NCT07674732Phase 21 site📍 Guangzhou Dechang Diao · Tests: Short-course Radiotherapy plus Chemotherapy, Nodal-Region Sparing Short-Course Radiotherapy Followed by Sequential Chem… A Pilot Study Evaluating β-hydroxybutyrate Supplementation Concomitant to Short-Course Radiotherapy Followed by Immunotherapy Combined With CAPEOX Neoadjuvant Therapy in Patients With Locally Advanced Rectal Cancer NCT07239466Phase 21 site📍 Wuhan Tao Zhang · Tests: Short-course radiotherapy, Capecitabine, Oxaliplatin, TME surgery, β-hydroxybutyrate NeoCSR-Omics Trial: CAPOX + Serplulimab Before vs. After Short-course RT in LARC NCT07898865Phase 21 site📍 Chongqing Chongqing University Cancer Hospital · Tests: radiotherapy, CAPOX (oxaliplatin/capecitabine), Serplulimab Efficacy and Safety Comparison of Short-course Radiotherapy Followed by CapeOX Chemotherapy Plus Toripalimab With or Without Concurrent Surufatinib in Neoadjuvant Therapy for Mid-to-low Localized Rectal Cancer of High-risk Criteria NCT07505472Phase 2, Phase 31 site📍 Changchun The First Hospital of Jilin University · Tests: Experimental Group, Control group Short-course Radiotherapy Combined With CapeOx and PD-1 Inhibitor After Local Excision for High-risk Early Rectal Cancer (TORCH-LE) NCT06455124Phase 21 site📍 Shanghai Fudan University · Tests: Radiation, PD-1 antibody, Capecitabine, Oxaliplatin Neoadjuvant Short-course Hypofractionated Radiotherapy Plus Adebrelimab and Platinum Chemotherapy in Locally Advanced Cervical Cancer: A Single-arm Phase II Trial NCT07731828Phase 21 site📍 Nanjing The First Affiliated Hospital with Nanjing Medical Universi… · Tests: Adebrelimab Efficacy and Safety of Retlirafusp Alfa Plus Bevacizumab and Chemotherapy With or Without Short-Course Radiotherapy in Patients With CRCLM NCT07728019Phase 21 site📍 Wuhan Union Hospital, Tongji Medical College, Huazhong University… · Tests: SCRT, Retlirafusp alfa Injection, Bevacizumab, CAPOX Node-Sparing Short-Course Radiotherapy Plus Chemotherapy, Bevacizumab and PD-1 Inhibitor in Metastatic pMMR/MSS Colorectal Cancer (MODIFI-CRC) NCT06958419Phase 2, Phase 31 site📍 Guangzhou Sixth Affiliated Hospital, Sun Yat-sen University · Tests: Node-Sparing Radiotherapy plus first-line therapy, First-line treatment
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy